You are here: Industry Insights > medicines

News List

FDA pushes for stronger warnings on insomnia medicines pharmatimes
May 10, 2019
FDA pushes for stronger warnings on insomnia medicines.
FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering fda
May 09, 2019
FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering.
FDA Adds Boxed Warning for Risk of Serious Injuries Caused by Sleepwalking with Certain Prescription Insomnia Medicines drugs
May 05, 2019
The Food and Drug Administration (FDA) is advising that rare but serious injuries have happened with certain common prescription insomnia medicines because of sleep behaviors, including sleepwalking, sleep driving, and engaging in other activities while n
Pharma firms step up plans to beat Brexit supply chain disruption europeanpharmaceuticalreview
April 19, 2019
The EMA has revised downwards the number of medicines expected to face Brexit-related supply disruptions from 108, earlier this year, to a current level of 39…
SPC manufacturing waiver is good news for Europe europeanpharmaceuticalreview
April 18, 2019
An SPC manufacturing waiver should be extremely beneficial for Europe and will increase net sales of the EU pharmaceutical industry…
Bristol-Myers Squibb shareholders approve Celgene acquisition worldpharmanews
April 16, 2019
Bristol-Myers Squibb shareholders approve Celgene acquisition.
Blood pressure and heart medication recalled by MHRA in UK europeanpharmaceuticalreview
April 16, 2019
The MHRA have announced another sartan-containing drug product over fears that it is contaminated with the carcinogen N‑nitrosodiethylamine…
Positive Scientific Advice from European Medicines Agency for Chronocort firstwordpharma
April 12, 2019
European Medicines Agency confirms the current clinical and regulatory path for Chronocort®...
ESMO drives EU-level action to tackle shortages of essential medicines europeanpharmaceuticalreview
April 12, 2019
Shortages of inexpensive, essential medicines: calling for tangible political commitments in the EU…
Novartis adds clinical and preclinical anti-inflammatory programs to portfolio with acquisition of IFM Tre worldpharmanews
April 04, 2019
Novartis announced that it is adding to its broad portfolio of immunomodulatory medicines with the planned acquisition of IFM Tre

Previous page 1 2 3 4 5 6 7 8 9 10 Next page